Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer

Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium

(2014) H. Saiga et al.   JOURNAL OF IMMUNOLOGY

Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease

(2011) Hsiu-Ting Tsai et al.   CLINICA CHIMICA ACTA

NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation

(2010) Chalinee Nuntagowat et al.   CLINICAL & EXPERIMENTAL METASTASIS

Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer

(2010) Yasuo Okada et al.   Odontology

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease

(2009) Xeni Provatopoulou et al.   BMC CANCER

Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy

(2009) S. Choi et al.   JOURNAL OF DENTAL RESEARCH

NGAL decreases E-cadherin-mediated cell–cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells

(2009) Limei Hu et al.   LABORATORY INVESTIGATION

The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury

(2009) A. Haase-Fielitz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer

(2008) Z. Tong et al.   CANCER RESEARCH

Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

(2008) E. R. Smith et al.   CLINICAL CANCER RESEARCH